Praxis Precision Medicines (PRAX) Current Deferred Revenue (2022 - 2024)
Praxis Precision Medicines (PRAX) posted Current Deferred Revenue of $1.2 million for Q3 2024, down 0.51% on a QoQ basis from $1.2 million in Q2 2024, and down 24.61% year-over-year from $1.6 million in Q4 2023.
Powered by 
Analysis
Praxis Precision Medicines (PRAX) Current Deferred Revenue (2022 - 2024) Analysis & Trends
Praxis Precision Medicines has reported Current Deferred Revenue for 3 years, with the latest figure at $1.2 million in Q3 2024.
- On a quarterly basis, Current Deferred Revenue fell 24.61% year-over-year to $1.2 million in Q3 2024; TTM through Sep 2024 was $1.2 million, a 24.61% decrease from a year earlier, with the FY2023 full-year figure at $1.4 million, down 50.6% from the prior year.
- Current Deferred Revenue was $1.2 million for Q3 2024 at Praxis Precision Medicines, down from $1.2 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $2.8 million in Q4 2022, with the low at $1.2 million in Q3 2024.
- Average Current Deferred Revenue over 3 years is $1.7 million, with a median of $1.5 million recorded in 2023.
- The largest YoY upside for Current Deferred Revenue was 24.61% in 2024 against a maximum downside of 50.61% in 2024.
- Over 3 years, Current Deferred Revenue stood at $2.8 million in 2022, then sank by 50.6% to $1.4 million in 2023, then dropped by 15.95% to $1.2 million in 2024.
- The last three Current Deferred Revenue figures came in at $1.2 million (Q3 2024), $1.2 million (Q2 2024), and $1.3 million (Q1 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 212.54 Bn | 198.55 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.84 Bn | 183.58 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 129.39 Bn | 121.54 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.06 Bn | 3.93 Bn |
| 5 | Moderna | 69.00 Bn | 63.87 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.67 Bn | 29.37 Bn | 992.69 Mn |
| 8 | Biogen | 32.37 Bn | 31.08 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.18 Bn | 28.87 Bn | 1.16 Mn |
| 10 | Praxis Precision Medicines | 8.34 Bn | 7.58 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.39 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 2.04 Mn |
| Mar 31, 2023 | 2.54 Mn |
| Dec 31, 2022 | 2.82 Mn |
API Access
Praxis Precision Medicines Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PRAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PRAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PRAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();